COMMUNIQUÉS West-GlobeNewswire

Good Salt Life Expands Clean Republic Multipurpose Disinfectant Label with Hospital-Disinfectant Kill Claims, Opening the Door to Healthcare and Animal Care Markets
04/08/2026
ATHENS, Ga., Aug. 04, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP), through its wholly owned subsidiary Good Salt Life , Inc., today announced a major expansion of the EPA-approved label for its [...]
ABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib
04/08/2026
11 tissue, blood, and cerebrospinal fluid biomarkers reflecting the biological cascade of neurodegeneration and neuroinflammation in PD respond in concert to risvodetinib treatment in patients with early untreated [...]
Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Amae Health Partners with Google Health Enterprise to Bring Wearable Data Integration to the Treatment of Complex Mental Health Conditions
04/08/2026
This collaboration reinforces Amae Health's precision psychiatry model, bringing the same level of measurement and precision to severe mental illness that is traditionally applied to physical healthcare SAN FRANCISCO, [...]
Betterbrand Highlights Surging Interest in Mullein as Consumers Turn to Natural Respiratory Wellness Solutions
04/08/2026
Clinically studied BetterLungs formulas position Betterbrand at the forefront of the growing mullein movement San Antonio, TX, Aug. 04, 2026 (GLOBE NEWSWIRE) -- SAN ANTONIO, TX — June 9, 2026 — Betterbrand, a science- [...]
Wave Life Sciences to Present at Upcoming Investor Conferences
04/08/2026
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Palvella Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
04/08/2026
First module of the rolling NDA for QTORIN™ rapamycin for microcystic lymphatic malformations submitted to FDA, with completion of the NDA submission on track for the second half of 2026 Preparing for a planned [...]
Remix Therapeutics to Present at 46th Annual Canaccord Genuity Growth Conference
04/08/2026
WATERTOWN, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Remix Therapeutics (Remix), Inc., a clinical-stage biotechnology company developing small molecule therapies to modulate RNA processing and address the underlying [...]
CAMP4 Therapeutics Announces Second Closing of $100 Million Private Placement
04/08/2026
Proceeds of $50.1 million will be used to support the Company’s advancement of CMP-002 for the treatment of SYNGAP1-related disorder CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (" [...]
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
04/08/2026
New agreement builds on commercialization and development of precision-fermented dairy proteins and enzymes while reinforcing Dyadic's diversified commercialization strategy JUPITER, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE [...]
Rhythm Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Update
04/08/2026
-- U.S. launch of IMCIVREE ® (setmelanotide) for acquired hypothalamic obesity (HO) starts strong with more than 400 patient start forms since FDA approval as of June 30, 2026 -- -- Second quarter 2026 net product [...]
Oblenio Announces First Patients Dosed in Innovative Phase 1a Trial of LBL-051 in Refractory Autoimmune Diseases
04/08/2026
-- First-in-human trial of LBL-051 is enrolling patients with refractory autoimmune diseases to rapidly generate broad proof of concept -- Cambridge, Mass., August 4, 2026 - Oblenio Bio (“Oblenio” or “the Company”) [...]
TELA Bio Announces Appointment of Heather Getz as Chief Executive Officer and Director
04/08/2026
MALVERN, Pa., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (“TELA Bio” or the “Company”), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, announced [...]
Aclarion Announces Nociscan® Now Available at Goodman Campbell Brain & Spine at Ascension St. Vincent, First Site in Indiana to Offer the Technology
04/08/2026
Partnership brings Nociscan for chronic low back pain to one of the nation's leading neurosurgery and spine care networks Goodman Campbell Brain & Spine is recognized nationally for its role in neurosurgery training [...]
ABBYY 2026 Hackathon Winner Accelerates Mortgage Auditing Review Leveraging Document AI and Large Language Models
04/08/2026
Annual ABBYY Ascend Developer Conference showcased the power of enterprises using a hybrid AI approach AUSTIN, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- ABBYY today announced SlateWorks Global Solutions (Slateworks) was [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04/08/2026
NEW HAVEN, Conn., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on August 1, 2026, Invivyd granted ten newly hired non-executive employees options to purchase an aggregate of 277, [...]
Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
04/08/2026
Positive longer-term open label study data further demonstrated nomlabofusp's well-characterized safety profile, sustained increases in skin frataxin levels, and continued improvements in key clinical outcome measures [...]
Tecan schedules conference call on August 11th to discuss half year 2026 financial results
04/08/2026
Männedorf, Switzerland, August 4, 2026 – The Tecan Group AG (SIX Swiss Exchange: TECN) will hold a conference call to discuss the financial results for the first half year 2026 on Tuesday, August 11th, 2026, at 09:00 [...]
Sagimet Biosciences to Participate in the Canaccord Genuity 46th Annual Growth Conference
04/08/2026
FOSTER CITY, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic [...]

Pages